The treatment of vesicoureteral reflux in children by endoscopic sub-mucosal intra-ureteral injection of dextranomer/hyaluronic acid
A case-series, multi-centre study
Keywords:
Vesicoureteral reflux; VUR; Dextranomer/hyaluronic acid; Dx\HA; Deflux; Modified STINGAbstract
Background: Vesicoureteral reflux is a risk factor for progressive renal damage. In addition to long-term antibiotic prophylaxis and open surgical re-implantation, endoscopic sub-mucosal intra-ureteral injection of implant material is a therapeutic alternative that gained a world-wide preference.
Objective: The aim of this study was to determine the effectiveness and safety of the implant material, dextranomer/hyaluronic acid, in a cohort of Saudi children with vesicoureteral reflux.
Methods: In this case-series study, 61 patients with vesicoureteral reflux, who were 7 months to 10 years old (mean age 2.6 years), underwent sub-mucosal intra-ureteral injection of dextranomer/hyaluronic acid at our institutions in the period from October 2003 to October 2013. The operative protocol was the same in all institutions. Dextranomer/hyaluronic acid was injected submucosally within the intramural ureter (modified STING). Renal ultrasonography was performed to detect the presence of hydronephrosis. At 6 weeks’ fluoroscopic voiding cystourethrograms were used to evaluate the success of the technique. Data were analysed by SPSS version 19 using Pearson Chi square, Fisher's Exact and Cramér's V test.
Results: Reflux was corrected in 44 patients out of 61 (72.13%) and in 60 (75.00%) out of 80 ureteric units. Statistically, there was no significant difference (p>0.05) in success rate of the technique according to gender, age group and unilateral vs. bilateral cases. The success rate was significantly (p=0.025) higher in the lower grades (I-III) (87.50%) compared to grade IV (73.53%) and grade V (50.00%). No complications related to the technique were reported. The technique had failed in 17 patients (27.87%) or 20 ureters (25.00%). These cases underwent open surgery.
Conclusion: Sub-mucosal intra-ureteral implantation with dextranomer/hyaluronic acid by the modified STING technique is a simple, safe and effective outpatient procedure for vesicoureteral reflux.
References
Jacobson SH, Hansson S, Jakobsson B. Vesicoureteric reflux: Occurrence and long term risks. Acta
Paediatr Suppl. 1999; 88(431): 22-30. doi: 10.1111/j.1651-2227.1999.tb01315.x. PMID: 10588268.
Sargent MA. What is the normal prevalence of vesicoureteral reflux? Pediatr Radiol. 2000; 30(9): 587-93.
doi: 10.1007/s002470000263. PMID: 11009294.
Bundy DG. Vesicoureteral reflux. Pediatr Rev. 2007; 28(2): e6-8. doi: 10.1542/pir.28-2-e6. PMID:
Montini G, Toffolo A, Zucchetta P, Dall'Amico R, Gobber D, Calderan A, et al. Antibiotic treatment for
pyelonephritis in children: multicentre randomised controlled noninferiority trial. BMJ. 2007; 335(7616):
doi: 10.1136/bmj.39244.692442.55. PMID: 17611232, PMCID: PMC1955287.
Elder JS. Guidelines for consideration for surgical repair of vesicoureteral reflux. Curr Opin Urol. 2000;
(6): 579-85. doi: 10.1097/00042307-200011000-00008. PMID: 11148729.
Mattoo TK. Vesicoureteral reflux and reflux nephropathy. Adv Chronic Kidney Dis. 2011; 18(5): 348-54.
doi: 10.1053/j.ackd.2011.07.006. PMID: 21896376, PMCID: PMC3169795.
American Urological Association: Report on the management of primary vesicoureteral reflux in children.
Baltimore: American Urological Association, 1997.
Smellie JM, Jodal U, Lax H, Möbius TT, Hirche H, Olbing H. Outcome at 10 years of severe vesicoureteric
reflux managed medically: Report of the International Reflux Study in Children. J Paediatr. 2001; 139(5):
-63. doi: 10.1067/mpd.2001.117583. PMID: 11713442.
Wan J, Greenfield SP, Talley M, Ng M. An analysis of social and economic factors associated with follow
up of patients with vesicoureteral reflux. J Urol. 1996; 156(2 Pt 2): 668-72. doi: 10.1016/S0022- 5347(01)65780-X. PMID: 8683756.
Mouriquand PDE. Surgical treatment of vesicoureteric reflux. In: Rob & Smith’s Operative Surgery:
Paediatric Surgery. Edited by Spitz L and Coran AG. London: Butterworth; 1995: 638642.
O’Donnell B, Puri P. Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J. 1984;
: 79. doi: 10.1136/bmj.288.6410.79.
Puri P, O’Donnell B. Correction of experimentally produced vesicoureteric reflux in the piglet by
intravesical injection of Teflon. Br Med J (Clin Res Ed). 1984; 289(6436): 5-7. doi:
1136/bmj.289.6436.5. PMID: 6428663, PMCID: PMC1442059.
Schulman CC. Uroplastique new microimplants for the endoscopic correction of reflux. Abstract of EAU
congress. 1992; 375: V59.
Chandrasekharam VV. Endoscopic treatment of vesicoureteric reflux with dextranomer/hyaluronic acid
copolymer (Deflux): Single surgeon experience with 48 ureters. Indian J Urol. 2013; 29(3): 173-6. doi:
4103/0970-1591.117269. PMID: 24082435, PMCID: PMC3783694.
Kirsch AJ, Perez-Brayfield M, Smith EA, Scherz HC. The modified sting procedure to correct
vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol.
; 171(6 Pt 1): 2413-6. doi: 10.1097/01.ju.0000127754.79866.7f. PMID: 15126864.
Aaronson IA, Rames RA, Greene WB, Walsh LG, Hasal UA, Garen PD. Endoscopic treatment of reflux
migration of Teflon to the lungs and brain. Eur Urol. 1993; 23(3): 394-9. PMID: 8508896.
Malizia AA Jr, Reiman HM, Myers RP, Sande JR, Barham SS, Benson RC Jr, et al. Migration and
granulomatous reaction after periurethral injection of polytef (Teflon). JAMA. 1984; 251(24): 3277-81.
doi: 10.1001/jama.1984.03340480059030. PMID: 6374180.
Allen O. Response to subdermal implantation of textured microimplants in humans. Aesthetic Plast Surg.
; 16(3): 227-30. doi: 10.1007/BF00190068. PMID: 1626459.
Stenberg A, Lackgren G. A new bio-implant for the endoscopic treatment of vesicoureteral reflux:
Experimental and short-term clinical results. J Urol. 1995; 154(2 Pt 2): 800-3. PMID: 7541869.
Stenberg AM, Sundin A, Larsson BS, Stenberg A. Lack of distant migration after injection of a 125-iodine
labelled dextranomer/hyaluronic acid copolymer: Preliminary results. J Urol. 1997; 158(5): 1937-41. doi:
1016/S0022-5347(01)64185-5.
Oswald J, Riccabona M, Lusuardi L, Bartsch G, Radmayr C. Prospective comparison and 1-year follow-up
of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer
injection for treatment of vesicoureteral reflux in children. Urology. 2002; 60(5): 894-7. doi:
1016/S0090-4295(02)01903-9. PMID: 12429323.
Lavelle MT, Conlin MJ, Skoog SJ. Subureteral injection of Deflux for correction of reflux: Analysis of
factors predicting success. Urology. 2005; 65(3): 564-7. doi: 10.1016/j.urology.2004.09.068. PMID:
Puri P, Pirker M, Mohanan N, Dawrant M, Dass L, Colhoun E. Subureteral dextranomer/hyaluronic acid
injection as first line treatment in the management of high grade vesicoureteral reflux. J Urol. 2006; 176(4
Pt 2): 1856-9. doi: 10.1016/j.juro.2006.03.124. PMID: 16945672.
Moltierno JA, Scherz HC, Kirsch AJ. Endoscopic treatment of vesicoureteric reflux using Dextranomer
Hyaluronic acid copolymer. J Pediatrc Urol. 2008; 4(3): 221-8. doi: 10.1016/j.jpurol.2007.11.015. PMID:
Puri P, Chertin B, Velayudham M, Dass L, Colhoun E. Treatment of vesicoureteral reflux by endoscopic
injection of dextranomer/hyaluronic acid copolymer: Preliminary results. J Urol. 2003; 170(4 Pt 2): 1541-4.
doi: 10.1097/01.ju.0000083924.44779.80. PMID: 14501655.
Perez-Brayfield M, Kirsch AJ, Hensle TW, Koyle MA, Furness P, Scherz HC. Endoscopic treatment with
dextranomer/hyaluronic acid for complex cases of vesicoureteral reflux. J Urol. 2004; 172(4 Pt 2): 1614-6.
doi: 10.1097/01.ju.0000139013.00908.1c. PMID: 15371773.
Chertin B, Colhoun E, Velayudham M, Puri P. Endoscopic treatment of vesicoureteral reflux: 11 to 17
years of followup. J Urol. 2002; 167(3): 1443-5. doi: 10.1016/S0022-5347(05)65340-2. PMID: 11832767.
Stenberg A, Hensle TW, Lackgren G. Vesicoureteral reflux: a new treatment algorithm. Curr Urol Rep.
; 3(2): 107-14. doi: 10.1007/s11934-002-0020-9. PMID: 12084201.
Elmore JM, Kirsch AJ, Lyles RH, Perez-Brayfield MR, Scherz HC. New contralateral vesicoureteral reflux
following dextranomer/hyaluronic acid implantation: incidence and identification of a high risk group. J
Urol. 2006; 175(3): 1097-1101. doi: 10.1016/S0022-5347(05)00405-2. PMID: 16469630.
Chertin B, Puri P. Endoscopic management of vesicoureteral reflux: does it stand the test of time? Eur
Urol. 2002; 42(6): 598-606. doi: 10.1016/S0302-2838(02)00447-5. PMID: 12477657.
Heidenreich A, Ozgur E, Becker T, Haupt G. Surgical management of vesicoureteral reflux in pediatric
patients. World J Urol. 2004; 22(2): 96-106. doi: 10.1007/s00345-004-0408-x. PMID: 15221260.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
